Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirley Hodgson

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a common variant associated with risk of endometrial cancerAmanda B Spurdle, Deborah J Thompson, Shahana Ahmed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2012
Genome-wide association study identifies a possible susceptibility locus for endometrial cancerJirong Long, Wei Zheng, Yong-Bing Xiang, et al.
Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.
JAMA|June 21, 2017
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, John L Hopper, Daniel R Barnes, et al.
Human Molecular Genetics|March 25, 2016
GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancerMaxine M Chen, Tracy A O'Mara, Deborah J Thompson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Endocrine-Related Cancer|September 3, 2015
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancerTracy A O'Mara, Dylan M Glubb, Jodie N Painter, et al.
Endocrine-Related Cancer|November 18, 2015
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerDeborah J Thompson, Tracy A O'Mara, Dylan M Glubb, et al.
Nature Genetics|May 3, 2016
Five endometrial cancer risk loci identified through genome-wide association analysisTimothy Ht Cheng, Deborah J Thompson, Tracy A O'Mara, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2014
Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected statusKaren A Pooley, Lesley McGuffog, Daniel Barrowdale, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a common variant associated with risk of endometrial cancerAmanda B Spurdle, Deborah J Thompson, Shahana Ahmed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2012
Genome-wide association study identifies a possible susceptibility locus for endometrial cancerJirong Long, Wei Zheng, Yong-Bing Xiang, et al.
Breast Cancer Research and Treatment|December 17, 2008
No evidence that GATA3 rs570613 SNP modifies breast cancer riskSharon E Johnatty, Fergus J Couch, Zachary Fredericksen, et al.
JAMA|June 21, 2017
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, John L Hopper, Daniel R Barnes, et al.
Human Molecular Genetics|March 25, 2016
GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancerMaxine M Chen, Tracy A O'Mara, Deborah J Thompson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Endocrine-Related Cancer|September 3, 2015
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancerTracy A O'Mara, Dylan M Glubb, Jodie N Painter, et al.
Endocrine-Related Cancer|November 18, 2015
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancerDeborah J Thompson, Tracy A O'Mara, Dylan M Glubb, et al.
Nature Genetics|May 3, 2016
Five endometrial cancer risk loci identified through genome-wide association analysisTimothy Ht Cheng, Deborah J Thompson, Tracy A O'Mara, et al.
Pageof 8